These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25583364)

  • 1. Cardiac effects of sertindole and quetiapine: analysis of ECGs from a randomized double-blind study in patients with schizophrenia.
    Nielsen J; Matz J; Mittoux A; Polcwiartek C; Struijk JJ; Toft E; Kanters JK; Graff C
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):303-11. PubMed ID: 25583364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sertindole on QTD and TPTE.
    Nielsen J; Andersen MP; Graff C; Kanters JK; Hardahl T; Dybbro J; Struijk JJ; Meyer JM; Toft E
    Acta Psychiatr Scand; 2010 May; 121(5):385-8. PubMed ID: 20085555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertindole causes distinct electrocardiographic T-wave morphology changes.
    Nielsen J; Graff C; Hardahl T; Andersen MP; Kristoffersen J; Struijk JJ; Toft E; Meyer JM
    Eur Neuropsychopharmacol; 2009 Oct; 19(10):702-7. PubMed ID: 19457646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sertindole on QTc interval in patients with schizophrenia.
    Atmaca M; Yavuzkir M; Mermi O; Topuz M; Kanmaz E; Tezcan E
    Neurosci Lett; 2008 Sep; 442(1):1-3. PubMed ID: 18639380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
    Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
    J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug safety and efficacy evaluation of sertindole for schizophrenia.
    Karamatskos E; Lambert M; Mulert C; Naber D
    Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QTc interval prolongation and antipsychotic drug treatments: focus on sertindole.
    Lindström E; Farde L; Eberhard J; Haverkamp W
    Int J Neuropsychopharmacol; 2005 Dec; 8(4):615-29. PubMed ID: 15963244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bilastine on T-wave morphology and the QTc interval: a randomized, double-blind, placebo-controlled, thorough QTc study.
    Graff C; Struijk JJ; Kanters JK; Andersen MP; Toft E; Tyl B
    Clin Drug Investig; 2012 May; 32(5):339-51. PubMed ID: 22393898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the safety and tolerability of sertindole.
    Hale AS
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S65-70. PubMed ID: 9690973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
    Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of mortality rates and cardiac dysrhythmias in post-marketing surveillance studies of sertindole and two other atypical antipsychotic drugs, risperidone and olanzapine.
    Wilton LV; Heeley EL; Pickering RM; Shakir SA
    J Psychopharmacol; 2001 Jun; 15(2):120-6. PubMed ID: 11448085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to Evaluating QT Prolongation of Quetiapine Fumarate in Late Stage of Clinical Development Using Concentration-QTc Modeling and Simulation in Japanese Patients With Bipolar Disorder.
    Fukushi R; Nomura Y; Katashima M; Komatsu K; Sato Y; Takada A
    Clin Ther; 2020 Aug; 42(8):1483-1493.e1. PubMed ID: 32792252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance.
    Pezawas L; Quiner S; Moertl D; Tauscher J; Barnas C; Küfferle B; Wolf R; Kasper S
    Int Clin Psychopharmacol; 2000 Jul; 15(4):207-14. PubMed ID: 10954060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phenotype characteristics of type 13 long QT syndrome with mutation in KCNJ5 (Kir3.4-G387R).
    Wang F; Liu J; Hong L; Liang B; Graff C; Yang Y; Christiansen M; Olesen SP; Zhang L; Kanters JK
    Heart Rhythm; 2013 Oct; 10(10):1500-6. PubMed ID: 23872692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertindole: dilemmas for its use in clinical practice.
    Pae CU
    Expert Opin Drug Saf; 2013 May; 12(3):321-6. PubMed ID: 23432404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of 12 weeks of treatment with sertindole or olanzapine in patients with chronic schizophrenia who did not respond successfully to their previous treatments: a randomized, double-blind, parallel-group, flexible-dose study.
    Kwon JS; Mittoux A; Hwang JY; Ong A; Cai ZJ; Su TP
    Int Clin Psychopharmacol; 2012 Nov; 27(6):326-35. PubMed ID: 22850268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology.
    Graff C; Andersen MP; Xue JQ; Hardahl TB; Kanters JK; Toft E; Christiansen M; Jensen HK; Struijk JJ
    Drug Saf; 2009; 32(7):599-611. PubMed ID: 19530746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis.
    Chung AK; Chua SE
    J Psychopharmacol; 2011 May; 25(5):646-66. PubMed ID: 20826552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia.
    Azorin JM; Strub N; Loft H
    Int Clin Psychopharmacol; 2006 Jan; 21(1):49-56. PubMed ID: 16317317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of paliperidone extended release and quetiapine on corrected QT intervals: a randomized, double-blind, placebo-controlled study.
    Hough DW; Natarajan J; Vandebosch A; Rossenu S; Kramer M; Eerdekens M
    Int Clin Psychopharmacol; 2011 Jan; 26(1):25-34. PubMed ID: 20881844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.